539730
FREDUN
Start SIP
Invest Now
Start SIP in FREDUN
Performance
- Low
- ₹1,675
- High
- ₹1,746
- 52 Week Low
- ₹635
- 52 Week High
- ₹1,999
- Open Price₹1,709
- Previous Close₹1,685
- Volume13,562
Investment Returns
- Over 1 Month -9.83%
- Over 3 Month + 30.49%
- Over 6 Month + 110.18%
- Over 1 Year + 129.63%
Smart Investing Starts Here Start SIP with Fredun Pharmaceuticals for Steady Growth!
Fredun Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 27.9
- PEG Ratio
- 0.4
- Market Cap Cr
- 805
- P/B Ratio
- 5.1
- Average True Range
- 104.89
- EPS
- -
- Dividend Yield
- 0
- MACD Signal
- -7.97
- RSI
- 48.47
- MFI
- 42.43
Fredun Pharmaceuticals Financials
Fredun Pharmaceuticals Technicals
EMA & SMA
Current Price
₹1,704.80
+
19.35
(1.15%)
- Bearish Moving Average 6
- Bullish Moving Average 10
- 20 Day
- ₹1,723.39
- 50 Day
- ₹1,669.36
- 100 Day
- ₹1,496.60
- 200 Day
- ₹1,261.57
Resistance and Support
1708.45
- R3 1,812.60
- R2 1,779.15
- R1 1,741.90
- S1 1,671.20
- S2 1,637.75
- S3 1,600.50
Fredun Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2025-11-08 | Quarterly Results | |
| 2025-09-25 | Preferential Issue of shares & Others | To consider 1. Issue Of Warrants. alia, to consider a proposal for fund raising up to Rs.120 crores by way of further public offer, rights issue, debt issue, preferential issue or any other method. |
| 2025-07-30 | Quarterly Results | |
| 2025-05-30 | Audited Results & Dividend | |
| 2025-02-04 | Quarterly Results |
Fredun Pharmaceuticals F&O
About Fredun Pharmaceuticals
- NSE Symbol
- FREDUN
- BSE Symbol
- 539730
- Managing Director & CFO
- Mr. Fredun Medhora
- ISIN
- INE194R01017
Similar Stocks to Fredun Pharmaceuticals
Fredun Pharmaceuticals FAQs
Fredun Pharmaceuticals share price is ₹1,704 As on 28 December, 2025 | 14:13
The Market Cap of Fredun Pharmaceuticals is ₹805 Cr As on 28 December, 2025 | 14:13
The P/E ratio of Fredun Pharmaceuticals is 27.9 As on 28 December, 2025 | 14:13
The PB ratio of Fredun Pharmaceuticals is 5.1 As on 28 December, 2025 | 14:13
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.